ﻻ يوجد ملخص باللغة العربية
A lot of time is spent searching for the most performing data mining algorithms applied in clinical diagnosis. The study set out to identify the most performing predictive data mining algorithms applied in the diagnosis of Erythemato-squamous diseases. The study used Naive Bayes, Multilayer Perceptron and J48 decision tree induction to build predictive data mining models on 366 instances of Erythemato-squamous diseases datasets. Also, 10-fold cross-validation and sets of performance metrics were used to evaluate the baseline predictive performance of the classifiers. The comparative analysis shows that the Naive Bayes performed best with accuracy of 97.4%, Multilayer Perceptron came out second with accuracy of 96.6%, and J48 came out the worst with accuracy of 93.5%. The evaluation of these classifiers on clinical datasets, gave an insight into the predictive ability of different data mining algorithms applicable in clinical diagnosis especially in the diagnosis of Erythemato-squamous diseases.
Longitudinal observational databases have become a recent interest in the post marketing drug surveillance community due to their ability of presenting a new perspective for detecting negative side effects. Algorithms mining longitudinal observation
It is crucial to provide compatible treatment schemes for a disease according to various symptoms at different stages. However, most classification methods might be ineffective in accurately classifying a disease that holds the characteristics of mul
The work presented in this paper is part of the cooperative research project AUTO-OPT carried out by twelve partners from the automotive industries. One major work package concerns the application of data mining methods in the area of automotive desi
The research in anomaly detection lacks a unified definition of what represents an anomalous instance. Discrepancies in the nature itself of an anomaly lead to multiple paradigms of algorithms design and experimentation. Predictive maintenance is a s
The current state-of-the-art deep neural networks (DNNs) for Alzheimers Disease diagnosis use different biomarker combinations to classify patients, but do not allow extracting knowledge about the interactions of biomarkers. However, to improve our u